Allergan Aesthetics, an AbbVie company, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP). The recommendation supports approval of Boey (trenibotulinumtoxinE) in the European Union. Key regulatory milestone for Boey The decision marks a key regulatory milestone for the injectable treatment. It targets temporary improvement of moderate to severe glabellar lines ...
Cosmo Pharmaceuticals reported encouraging long-term results for its experimental male hair loss treatment. The treatment showed sustained hair growth and a strong safety profile after one year of clinical use. The company said its topical drug, clascoterone, delivered continued hair regrowth in men with androgenetic alopecia, a common form of male pattern baldness. The findings come from an extension of ...